Nadler and Democrats must zero in on corporate power: Look at prescription drug pricing and megamergers op-eds, DavidDavid GoodfriendDecember 11, 2018antitrustComment Twitter LinkedIn0 Reddit Tumblr Pinterest0 0 Likes